rct
    2009

    Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome

    Dolin BJ

    Published in Methods and Findings in Experimental and Clinical Pharmacology

    Abstract

    Controlled pilot study of a proprietary Bacillus coagulans preparation in diarrhea-predominant IBS.

    Key Findings

    Patients receiving GanedenBC30 had fewer daily bowel movements than placebo in diarrhea-predominant IBS in this controlled pilot study.

    Conclusions

    Preliminary evidence supports B. coagulans for diarrhea-predominant IBS.

    Limitations

    Pilot study, very small sample, manufacturer-sponsored.

    Supplements Studied

    Patients receiving GanedenBC30 had fewer daily bowel movements than placebo in diarrhea-predominant IBS in this controlled pilot study.

    Study Details

    Year:2009
    Sample Size:52
    Duration:8 weeks
    Quality Score:4/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.